NFKB1 and cancer: Similarly, NF-κB is activated in drug-resistant cancer cells [27], and CERT is highly expressed in drug-resistant human cancers [60, 62, 63]; whereas, a lower CERT expression level is reported in some human cancers in the absence of chemotherapies [59, 65, 66].